M. Borok

Xing-quan Zhang, S. Fiorillo, T. Campbell, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HHV-8 peripheral-blood viral load and the titer of antibodies against HHV-8.

T. Campbell, M. Borok, L. Gwanzura, 1999, The New England journal of medicine.

Gender Differences in AIDS-Associated Kaposi Sarcoma in Harare, Zimbabwe

T. Campbell, M. Borok, L. Gwanzura, 2007, Journal of acquired immune deficiency syndromes.

Aids and cancer in Africa: the evolving epidemic in Zimbabwe.

D. Parkin, M. Bassett, E. Chokunonga, 1999, AIDS.

AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.

T. Campbell, M. Borok, A. Makadzange, 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe.

T. Campbell, M. Borok, A. Weinberg, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cancer incidence among people living with HIV in Zimbabwe: A record linkage study

M. Egger, J. Bohlius, A. Spoerri, 2021, Cancer reports.

Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments.

D. Dittmer, A. Mosam, T. Campbell, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinicopathological features of Zimbabwean patients with sustained proteinuria.

M. Borok, K. Nathoo, K. Porter, 1997, The Central African journal of medicine.

Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.

R. Schooley, K. Erlandson, S. Fiorillo, 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Castleman disease

B. Damania, A. Carbone, A. Gloghini, 2019, Nature Reviews Disease Primers.

Alpha-galactosidase A deficiency (Fabry's disease) in a black Zimbabwean.

M. Borok, R. Gabriel, 1993, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Impact of Antiretroviral Therapy on Cancer Treatment Outcomes among People Living with HIV in Low- and Middle-Income Countries: a Systematic Review

M. Borok, T. Uldrick, Rachel A. Bender Ignacio, 2021, Current HIV/AIDS Reports.

WT1 Tumor Antigen is Overexpressed in Kaposi Sarcoma and is Regulated by KSHV vFLIP

A. Semeere, E. Cesarman, D. Scheinberg, 2021, medRxiv.

Utilisation of Medical Services and Outcomes at Adult Rape Clinic at Parirenyatwa Group of Hospitals, Zimbabwe.

P. Nsubuga, M. Borok, Gerald Shambira, 2019, African journal of reproductive health.

Quality care at the end of life in Africa

M. Borok, T. Ngoma, V. Habiyambere, 2003, BMJ : British Medical Journal.

Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial

W. Wachsman, C. Rinaldo, C. Moser, 2020, The Lancet.

Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers

E. Cesarman, J. Sparano, M. Borok, 2020, JCO global oncology.

The incidence of oesophageal cancer in Eastern Africa: identification of a new geographic hot spot?

R. Hiatt, D. Parkin, K. Van Loon, 2015, Cancer epidemiology.

Survival from childhood cancers in Eastern Africa: A population‐based registry study

D. Parkin, D. M. Parkin, E. Chokunonga, 2018, International journal of cancer.

Evaluation of a training intervention to improve cancer care in Zimbabwe: Strategies to Improve Kaposi Sarcoma Outcomes (SIKO), a prospective community‐based stepped‐wedge cluster randomized trial

Camille M. Moore, J. Kutner, Thomas B Campbell, 2022, Journal of the International AIDS Society.

Desirable Services and Guidelines for the Treatment and Palliative Care of HIV Disease Patients with Cancer in Africa: A World Health Organization Consultation *

S. Fonn, M. Borok, T. Ngoma, 2003, Journal of palliative care.

HIV Status Disclosure to Perinatally-Infected Adolescents in Zimbabwe: A Qualitative Study of Adolescent and Healthcare Worker Perspectives

R. Ferrand, M. Borok, C. Ndhlovu, 2014, PloS one.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, Lancet.

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

A. Breckenridge, P. Kaleebu, D. Pillay, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010

D. Parkin, E. Chokunonga, M. Borok, 2013, International journal of cancer.

Trends in cervical cancer incidence in sub-Saharan Africa

D. Parkin, M. Borok, H. Wabinga, 2020, British Journal of Cancer.

Complete regression of early diffuse B-cell lymphoma in an HIV-positive patient on antiretroviral therapy alone

M. Borok, A. Ramsay, R. Makunike-Mutasa, 2011, International journal of STD & AIDS.

Cervical cancer survival in sub‐Saharan Africa by age, stage at diagnosis and Human Development Index: A population‐based registry study

D. Parkin, E. Chokunonga, M. Borok, 2020, International journal of cancer.

As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial

Jeffrey N. Martin, Minhee Kang, D. Dittmer, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical presentation and diagnosis of adult patients with non‐Hodgkin lymphoma in Sub‐Saharan Africa

A. Jemal, D. Parkin, C. Wickenhauser, 2020, British journal of haematology.

Changes in the Incidence of Cancer in Bulawayo, Zimbabwe over a 50-Year Period

D. Parkin, E. Chokunonga, M. Borok, 2021, Cancer Epidemiology, Biomarkers & Prevention.

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT

K. Ruxrungtham, A. Kelleher, M. Karyana, 2022, HIV research & clinical practice.

Trends in cervical cancer incidence in sub-Saharan Africa

M. Borok, H. Wabinga, N. Buziba, 2020, British Journal of Cancer.

Breast cancer survival in sub‐Saharan Africa by age, stage at diagnosis and human development index: A population‐based registry study

I. Soerjomataram, D. Parkin, P. Mcgale, 2019, International journal of cancer.

Cancer survival in a southern African urban population

H. Brenner, D. Parkin, R. Sankila, 2004, International journal of cancer.

Treatment of AIDS‐associated Kaposi's sarcoma in Zimbabwe: Results of a randomized quality of life focused clinical trial

Harvey Schipper, M. Cheang, M. Borok, 2005, International journal of cancer.

Survival of cervix cancer patients in Harare, Zimbabwe, 1995–1997

R. Sankila, D. M. Parkin, E. Chokunonga, 2004, International journal of cancer.

Pharmacogenetics and Adverse Events in the Use of Fluoropyrimidine in a Cohort of Cancer Patients on Standard of Care Treatment in Zimbabwe

C. Masimirembwa, M. Borok, N. Ndlovu, 2023, Journal of personalized medicine.

Compartmentalized T cell profile in the lungs of patients with HIV-1-associated pulmonary Kaposi sarcoma

B. Corleis, D. Kwon, R. Lyall, 2021, Medicine.

The incidence and histo-pathological characteristics of colorectal cancer in a population based cancer registry in Zimbabwe.

R. Ramesar, S. Rusakaniko, E. Chokunonga, 2016, Cancer epidemiology.

Black–white differences in cancer risk in Harare, Zimbabwe, during 1991–2010

P. Sasieni, E. Chokunonga, M. Borok, 2016, International journal of cancer.

Medical Education Partnership Initiative (MEPI) in Zimbabwe: Outcomes and Challenges

M. Barry, Thomas B Campbell, E. Havranek, 2018, Global Health: Science and Practice.

Health Education Advanced Leadership for Zimbabwe (Healz): Developing the Infrastructure to Support Curriculum Reform

M. Barry, Thomas B Campbell, M. Borok, 2018, Annals of global health.

Innovations to Enhance the Quality of Health Professions Education at the University of Zimbabwe College of Health Sciences–NECTAR Program

M. Barry, Thomas B Campbell, M. Borok, 2014, Academic medicine : journal of the Association of American Medical Colleges.

Feasibility and sustainability of an interactive team-based learning method for medical education during a severe faculty shortage in Zimbabwe

Thomas B Campbell, M. Borok, E. Aagaard, 2014, BMC medical education.

Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting

D. Katzenstein, S. Rusakaniko, M. Borok, 2006, Journal of Translational Medicine.

Early progression and immune reconstitution inflammatory syndrome during treatment of mild-to-moderate Kaposi sarcoma in sub-Saharan Africa and South America: Incidence, long-term outcomes and effects of early chemotherapy.

Minhee Kang, D. Dittmer, O. Martínez-Maza, 2020, Journal of acquired immune deficiency syndromes.

Castleman disease

B. Damania, A. Carbone, A. Gloghini, 2021, Nature Reviews Disease Primers.

Treatment and Survival Among Patients With Colorectal Cancer in Sub-Saharan Africa: A Multicentric Population-Based Follow-Up Study.

A. Jemal, D. Parkin, M. Borok, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Evaluation of treatments for HIV-associated Kaposi sarcoma in Africa

M. Borok, S. Krown, 2021, Infectious agents and cancer.

Setting the Research Agenda in a Resource-Limited Setting—Viewpoint

M. Borok, N. Busakhala, T. Makadzange, 2014, Journal of acquired immune deficiency syndromes.

Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings

O. Martínez-Maza, Jeannette Y Lee, T. Campbell, 2023, Journal of acquired immune deficiency syndromes.

Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.

R. Schooley, S. Fiorillo, T. Campbell, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, The Lancet.

Presence of Betapapillomavirus in Kaposi sarcoma lesions

B. Stray-Pedersen, F. Muchemwa, M. Borok, 2014, Journal of medical virology.

CARDIOTOXICITY AND PHARMACOGENETICS OF DOXORUBICIN IN BLACK ZIMBABWEAN BREAST CANCER PATIENTS.

C. Masimirembwa, T. Campbell, M. Borok, 2023, British journal of clinical pharmacology.

Wilms’ tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP

A. Semeere, D. Scheinberg, C. Moser, 2024, PLoS pathogens.

Complete regression of early diffuse B-cell lymphoma in an HIV-positive patient on antiretroviral therapy alone

M. Borok, A. Ramsay, R. Makunike-Mutasa, 2011, International journal of STD & AIDS.

Kaposi's sarcoma in Zimbabwe. II. Peripheral lymphocytes, immunoglobulin G levels and HIV antibody positivity.

M. Borok, R. Downing, D. de Villiers, 1988, Journal of clinical & laboratory immunology.

D. Katzenstein, S. Rusakaniko, M. Borok, 2006, Journal of Translational Medicine.